Edit |   |
---|---|
Antigenic Specificity | KLKB1, Human (Lanadelumab biosimilar) |
Clone | Lanadelumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, IHC, FCM, IP, IF, FuncS, PK |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human KLKB1 Recombinant Antibody. Lanadelumab (INN, trade name Takhzyro) is a human monoclonal antibody (class IgG1 kappa) that targets plasma kallikrein (pKal) in order to promote prevention of angioedema in patients with hereditary angioedema. |
Immunogen | n/a |
Other Names | Anti-KLKB1 Recombinant Antibody, Research Grade Lanadelumab, Anti-Human KLKB1 Recombinant Antibody, X124-G01, DX-2930, Antibody Drug Analogues, Monoclonal Antibody, YR1413, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1426055-14-2 |
Catalog # | YR1413 |
Price | please inquire |
Order / More Info | KLKB1, Human (Lanadelumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |